查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827710

2025年全球心臟瓣膜市场报告

Cardiac Valve Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心臟瓣膜市场快速扩张，从2024年的108.9亿美元成长至2025年的124.1亿美元，复合年增长率达13.9%。过去的增长可归因于人口老化及其导致的心臟瓣膜疾病发病率上升、肥胖和高血压等危险因素的患病率上升、心臟瓣膜疾病诊断和影像学技术的进步、心臟健康和心臟瓣膜疾病宣传活动和教育的开展，以及微创和经导管心臟瓣膜疾病治疗技术的进步。

预计未来几年心臟瓣膜市场将快速成长，到 2029 年将达到 212.2 亿美元，复合年增长率为 14.4%。预测期内的成长动力来自以下因素：对生物工程和组织工程心臟瓣膜的需求不断增长、全球人口老化、对心臟瓣膜疾病治疗的需求、心臟瓣膜疾病患者的远距远端医疗和远端患者监护、心臟瓣膜疾病手术技术的改进和机器人辅助治疗，以及 3D 列印在个人化心臟瓣膜製造中的应用。预测期内的主要趋势包括瓣膜置换和修復技术的进步、人工智慧 (AI) 在瓣膜疾病检测和治疗计划中的应用、3D 列印在个人化心臟瓣膜製造中的应用、瓣膜置换和修復技术的进步、手术技术的改进和机器人辅助瓣膜手术。

心臟瓣膜是一种人工装置，用于调节心臟内的血流，并确保血液从心臟单向流向身体其他部位。这些植入式装置在替换因各种疾病而停止功能的受损瓣膜方面发挥着重要作用。心臟瓣膜的主要作用是维持血液在心臟内以及连接心臟的主要血管中的正常流动。

心臟瓣膜的主要类型包括组织瓣膜、经导管瓣膜、机械瓣膜等。组织瓣膜用于开胸手术和微创手术，以防止血管内血栓形成。这些瓣膜由捐赠者的耐用且柔韧的动物组织製成，用于心臟瓣膜修復和置换术。心臟瓣膜的修復或置换适用于心臟的不同部位，包括主动脉瓣和二尖瓣。心臟瓣膜的最终使用者包括医院、诊所、专科中心、心臟研究机构和其他医疗机构。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供心臟瓣膜市场统计数据，例如全球市场规模、区域份额、心臟瓣膜市场份额竞争对手、详细的心臟瓣膜细分市场、市场趋势和机会，以及您在心臟瓣膜行业取得成功所需的数据。本心臟瓣膜市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年预测成长率为14.4%，较我们先前对该市场的预测略有下降0.1%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接波及美国，导致来自加拿大和奥地利等主要地区的心包组织补片和支架瓣膜组件的供应链中断，从而可能导致瓣膜置换术等待时间延长和设备价格上涨。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地蔓延。

心血管疾病的日益普及推动了心臟瓣膜市场的成长。吸烟、肥胖、缺乏运动等心血管压力因素导致心血管疾病的发生率逐渐上升。冠状动脉疾病是常见的原因，其特征是动脉中脂肪斑块的堆积。心臟相关疾病的激增推动了对用于治疗心臟瓣膜问题的心臟瓣膜的需求。根据世界卫生组织 (WHO) 的数据，截至 2023 年 9 月，心血管疾病占全球非传染性疾病 (NCD) 或慢性疾病相关死亡人数的很大一部分，约为 74%。

预计心臟瓣膜市场的扩张将受到医疗支出成长的推动。医疗保健支出涵盖与医疗保健产品和服务相关的成本，是支持心臟瓣膜研发和普及的关键因素。 2022年11月，加拿大卫生资讯研究所报告称，2022年医疗保健支出将成长0.8%，达到3,310亿美元，而2021年的成长率为7.6%。医疗保健支出成长的趋势是心臟瓣膜市场成长的驱动因素。

心臟瓣膜市场的一个显着趋势是技术进步的融合。产业主要参与企业正专注于新生血管心臟瓣膜植入物、环状成形术术环和机器人手术等创新技术，以提升其市场占有率。这些技术进步有助于为心臟病提供微创治疗方案，并为患者提供保护，使其免受心肌梗塞和心臟麻痹等危及生命的疾病的侵害。 2022年9月，美国领先的医疗科技公司Edwards推出了Sapien 3 Ultra Resilia经导管心臟瓣膜，该瓣膜采用抗钙化技术。此技术平台旨在不可逆地阻断生物瓣膜中的钙结合位点。

心臟瓣膜市场的主要企业正在积极开发创新产品，例如推出下一代经导管主动脉瓣植入 (TAVI) 系统，这些系统正在推动市场收益。美国知名医疗设备公司雅培于 2022 年 12 月推出了 Navitor TAVI 系统。这种自膨胀瓣膜旨在治疗有症状的严重主动脉瓣狭窄且被认为开胸手术风险高或极高的患者。 Navitor TAVI 系统融合了智慧设计功能，包括智慧 PVL 密封 NaviSeal 袖带、稳定精确的放置、卓越的个位数梯度和不受影响的小血管通路，可适应从常规到具有挑战性的各种解剖结构。

2022年1月，专注于结构性心臟病治疗的中国公司启明医疗完成了对以色列医疗设备公司CardioValve的收购，后者专注于经股动脉二尖瓣置换系统的研发。这项策略性倡议将使启明医疗得以推进其在欧洲和美国的临床研究，同时加速其在中国的临床开发和商业化进程。此次收购使启明医疗成为中国治疗二尖瓣和瓣膜闭锁不全最全面的平台。

心臟瓣膜市场的主要企业包括雅培实验室、Colibri Heart Valve LLC、TTK HealthCare Limited、Artivion Inc.、Edwards Lifesciences Corporation、波士顿科学公司、Jenavalve Technology Inc.、CryoLife Inc.、乐普医疗科技有限公司、Braille Biomedical、Sorin Group、Micro Interventional Devices Inc.、美敦科技公司、爱德华Ltd.、Auto Tissue Berlin GmbH、On-X Life Technologies Inc.、Thubrikar Aortic Valve Inc. 和 LifeNet Health Inc.。

2024年，北美是心臟瓣膜市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。心臟瓣膜市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

心臟瓣膜市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

心臟瓣膜市场包括三尖瓣和肺动脉瓣的销售。该市场的价值是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心臟瓣膜：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球心臟瓣膜市场：成长率分析
  • 全球心臟瓣膜市场表现：规模与成长，2019-2024
  • 全球心臟瓣膜市场预测：规模与成长，2024-2029年，2034年
  • 全球心臟瓣膜：总目标市场（TAM）

第六章 市场细分

  • 全球心臟瓣膜市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 组织心臟瓣膜
  • 经导管心臟瓣膜
  • 人工心臟瓣膜
  • 其他的
  • 全球心臟瓣膜市场分布、表现及预测（2019-2024、2024-2029、2034）
  • 主动脉瓣
  • 二尖瓣
  • 其他的
  • 全球心臟瓣膜市场（按治疗、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 心臟瓣膜修復
  • 心臟瓣膜置换术
  • 全球心臟瓣膜市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 专业中心
  • 心臟研究所
  • 其他的
  • 全球心臟瓣膜市场：组织心臟瓣膜细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物瓣膜（例如猪、牛）
  • 同种异体瓣膜
  • 全球心臟瓣膜市场：经导管心臟瓣膜细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 经导管主动脉瓣置入术（TAVI）瓣膜
  • 经导管二尖瓣瓣膜修復
  • 全球心臟瓣膜市场：人工心臟瓣膜细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 斜盘阀
  • 双叶瓣
  • 笼式球阀
  • 全球心臟瓣膜市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 导管
  • 有支架瓣膜和无支架瓣膜

第七章 区域和国家分析

  • 全球心臟瓣膜市场：2019-2024 年、2024-2029 年和 2034 年区域表现和预测
  • 全球心臟瓣膜市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 心臟瓣膜市场：竞争格局
  • 心臟瓣膜市场：公司简介
    • Abbott Laboratories
    • Colibri Heart Valve LLC
    • TTK HealthCare Limited
    • Artivion Inc.
    • Edwards Lifesciences Corporation

第31章：其他领先和创新企业

  • Boston Scientific Corporation
  • Jenavalve Technology Inc.
  • CryoLife Inc.
  • Lepu Medical Technology Co. Ltd.
  • Braile Biomedical
  • Sorin Group
  • Micro Interventional Devices Inc.
  • Medtronic Inc.
  • Lepu Medical Technology
  • Edward Lifesciences Corporation
  • Xeltis AG
  • Meril Life Sciences Pvt. Ltd.
  • Auto Tissue Berlin GmbH
  • On-X Life Technologies Inc.
  • Thubrikar Aortic Valve Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029 年心臟瓣膜市场：提供新机会的国家
  • 2029 年心臟瓣膜市场：细分市场带来新机会
  • 2029年心臟瓣膜市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21193u

Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.

The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac valve market size has grown rapidly in recent years. It will grow from $10.89 billion in 2024 to $12.41 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to aging population and the associated increase in valvular heart disease, growth in the prevalence of risk factors like obesity and hypertension, improved diagnostic and imaging technologies for valve diseases, awareness campaigns and education on heart health and valve disease, and development of minimally invasive and transcatheter valve procedures.

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $21.22 billion in 2029 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing demand for bioengineered and tissue-engineered heart valves, aging global population andThe need for valve disease treatment, telemedicine and remote patient monitoring for valve patients, enhanced surgical techniques and robotics-assisted valve procedures, and adoption of 3D printing for personalized heart valve manufacturing. Major trends in the forecast period include advancements in valve replacement and repair techniques, integration of artificial intelligence (ai) for valve disease detection and treatment planning, adoption of 3D printing for personalized heart valve manufacturing, advancements in valve replacement and repair techniques, and enhanced surgical techniques and robotics-assisted valve procedures.

The forecast of 14.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for pericardial tissue patches and stent-mounted valve assemblies, sourced from key regions such as Canada and Austria, which could lead to longer wait times for valve replacement procedures and higher device prices.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.

The expansion of the cardiac valves market is expected to be fueled by the increasing healthcare expenditure. Healthcare expenditure, encompassing costs associated with healthcare goods and services, is a critical factor supporting the development and accessibility of cardiac valves. In November 2022, the Canadian Institute for Health Information reported a rise in healthcare expenditure to 0.8%, amounting to $331 billion in 2022, compared to 7.6% in 2021. This upward trend in healthcare spending is a significant driver of the growth observed in the cardiac valves market.

A notable trend in the cardiac valve market is the integration of technological advancements. Major players in the industry are focusing on innovative technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to enhance their market presence. These technological advancements contribute to less invasive treatment options for heart diseases, offering patients protection against life-threatening conditions such as heart stroke and cardiac arrest. In September 2022, Edwards, a leading US-based medical technology company, introduced the Sapien 3 Ultra Resilia transcatheter heart valve featuring anti-calcification technology. This technology platform was designed to irreversibly block calcium binding sites in bioprosthetic valves.

Major companies within the cardiac valves market are actively engaged in the development of innovative products, exemplified by the introduction of next-generation transcatheter aortic valve implantation (TAVI) systems to drive market revenues. Abbott, a prominent US-based medical device company, launched the Navitor TAVI system in December 2022. This self-expanding valve is designed to treat patients with symptomatic severe native aortic stenosis deemed at high or extreme risk for open-heart surgery. The Navitor TAVI system incorporates intelligent design features, including the smart PVL-sealing NaviSeal Cuff, stable and accurate placement, exceptional single-digit gradients, and uncompromised small vessel access, catering to a broad spectrum of routine to challenging anatomies.

In January 2022, Venus Medtech, a China-based company specializing in structural heart disease treatment, completed the acquisition of Cardiovalve Ltd., an Israel-based medical device company focused on developing a transfemoral mitral valve replacement system. This strategic move enables Venus Medtech to advance clinical research in Europe and the United States while accelerating clinical development and commercialization in China. The acquisition positions Venus Medtech as China's most comprehensive platform for treating mitral and tricuspid regurgitation.

Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Valve Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac valve market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tissue Heart Valves; Transcatheter Heart Valves; Mechanical Heart Valves; Other Types
  • 2) By Position: Aortic Valve; Mitral Valve; Other Positions
  • 3) By Treatment: Cardiac Valve Repair; Cardiac Valve Replacement
  • 4) By End-Users: Hospital And Clinics; Specialty Centers; Cardiac Research Institute; Other End Users
  • Subsegments:
  • 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine); Homograft Valves
  • 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves; Transcatheter Mitral Valve Repair Valves
  • 3) By Mechanical Heart Valves: Tilting Disc Valves; Bileaflet Valves; Caged Ball Valves
  • 4) By Other Types: Conduits; Stented vs. Stentless Valves
  • Companies Mentioned: Abbott Laboratories; Colibri Heart Valve LLC; TTK HealthCare Limited; Artivion Inc.; Edwards Lifesciences Corporation; Boston Scientific Corporation; Jenavalve Technology Inc.; CryoLife Inc.; Lepu Medical Technology Co. Ltd.; Braile Biomedical; Sorin Group; Micro Interventional Devices Inc.; Medtronic Inc.; Lepu Medical Technology; Edward Lifesciences Corporation; Xeltis AG; Meril Life Sciences Pvt. Ltd.; Auto Tissue Berlin GmbH; On-X Life Technologies Inc.; Thubrikar Aortic Valve Inc.; LifeNet Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiac Valve Market Characteristics

3. Cardiac Valve Market Trends And Strategies

4. Cardiac Valve Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac Valve Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiac Valve PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiac Valve Market Growth Rate Analysis
  • 5.4. Global Cardiac Valve Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiac Valve Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiac Valve Total Addressable Market (TAM)

6. Cardiac Valve Market Segmentation

  • 6.1. Global Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Heart Valves
  • Transcatheter Heart Valves
  • Mechanical Heart Valves
  • Other Types
  • 6.2. Global Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortic Valve
  • Mitral Valve
  • Other Positions
  • 6.3. Global Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Valve Repair
  • Cardiac Valve Replacement
  • 6.4. Global Cardiac Valve Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital And Clinics
  • Specialty Centers
  • Cardiac Research Institute
  • Other End Users
  • 6.5. Global Cardiac Valve Market, Sub-Segmentation Of Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioprosthetic Valves (e.g., porcine, bovine)
  • Homograft Valves
  • 6.6. Global Cardiac Valve Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Aortic Valve Implantation (TAVI) Valves
  • Transcatheter Mitral Valve Repair Valves
  • 6.7. Global Cardiac Valve Market, Sub-Segmentation Of Mechanical Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tilting Disc Valves
  • Bileaflet Valves
  • Caged Ball Valves
  • 6.8. Global Cardiac Valve Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conduits
  • Stented vs. Stentless Valves

7. Cardiac Valve Market Regional And Country Analysis

  • 7.1. Global Cardiac Valve Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiac Valve Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Valve Market

  • 8.1. Asia-Pacific Cardiac Valve Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Valve Market

  • 9.1. China Cardiac Valve Market Overview
  • 9.2. China Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Valve Market

  • 10.1. India Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Valve Market

  • 11.1. Japan Cardiac Valve Market Overview
  • 11.2. Japan Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Valve Market

  • 12.1. Australia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Valve Market

  • 13.1. Indonesia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Valve Market

  • 14.1. South Korea Cardiac Valve Market Overview
  • 14.2. South Korea Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Valve Market

  • 15.1. Western Europe Cardiac Valve Market Overview
  • 15.2. Western Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Valve Market

  • 16.1. UK Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Valve Market

  • 17.1. Germany Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Valve Market

  • 18.1. France Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Valve Market

  • 19.1. Italy Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Valve Market

  • 20.1. Spain Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Valve Market

  • 21.1. Eastern Europe Cardiac Valve Market Overview
  • 21.2. Eastern Europe Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Valve Market

  • 22.1. Russia Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Valve Market

  • 23.1. North America Cardiac Valve Market Overview
  • 23.2. North America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Valve Market

  • 24.1. USA Cardiac Valve Market Overview
  • 24.2. USA Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Valve Market

  • 25.1. Canada Cardiac Valve Market Overview
  • 25.2. Canada Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Valve Market

  • 26.1. South America Cardiac Valve Market Overview
  • 26.2. South America Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Valve Market

  • 27.1. Brazil Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Valve Market

  • 28.1. Middle East Cardiac Valve Market Overview
  • 28.2. Middle East Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Valve Market

  • 29.1. Africa Cardiac Valve Market Overview
  • 29.2. Africa Cardiac Valve Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiac Valve Market, Segmentation By Position, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiac Valve Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Valve Market Competitive Landscape And Company Profiles

  • 30.1. Cardiac Valve Market Competitive Landscape
  • 30.2. Cardiac Valve Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Colibri Heart Valve LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. TTK HealthCare Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Artivion Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Valve Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Jenavalve Technology Inc.
  • 31.3. CryoLife Inc.
  • 31.4. Lepu Medical Technology Co. Ltd.
  • 31.5. Braile Biomedical
  • 31.6. Sorin Group
  • 31.7. Micro Interventional Devices Inc.
  • 31.8. Medtronic Inc.
  • 31.9. Lepu Medical Technology
  • 31.10. Edward Lifesciences Corporation
  • 31.11. Xeltis AG
  • 31.12. Meril Life Sciences Pvt. Ltd.
  • 31.13. Auto Tissue Berlin GmbH
  • 31.14. On-X Life Technologies Inc.
  • 31.15. Thubrikar Aortic Valve Inc.

32. Global Cardiac Valve Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Valve Market

34. Recent Developments In The Cardiac Valve Market

35. Cardiac Valve Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiac Valve Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiac Valve Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiac Valve Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer